NETTER-1 Studie zur 177Lu-DOTA-TATE Therapie bei fortgeschrittenen neuroendokrinen Tumoren
Crossref DOI link: https://doi.org/10.1007/s00117-017-0221-3
Published Online: 2017-02-09
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Derlin, T.
License valid from 2017-02-09
